Breithorn Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Breithorn Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-63,324	Closed	-$322K	–	46
2016 Q3	$322K	Hold	63,324	–	–	0.24%	35
2016 Q2	$378K	Hold	63,324	–	–	0.29%	37
2016 Q1	$288K	Sell	63,324 -142,152	-69%	-$633K	0.2%	41
2015 Q4	$925K	Sell	205,476 -14,481	-7%	-$61.1K	0.63%	32
2015 Q3	$697K	Buy	219,957 +89,511	+69%	+$272K	0.5%	32
2015 Q2	$395K	Buy	+130,446	New	+$367K	0.25%	35

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Breithorn Capital Management's ENZ Position: Q4 2016 in Review

Breithorn Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q4 2016, closing a stake of 63,324 shares — an estimated $322K sold.

Breithorn Capital Management first reported a position in ENZ in Q2 2015 and held it in 6 quarters. The position peaked at $925K in Q4 2015. 109 funds tracked by Wall St. Rank hold ENZ as of Q4 2016.

Breithorn Capital Management reported no remaining Enzo Biochem, Inc. position as of Q4 2016 after selling out during the quarter.
Breithorn Capital Management sold 63,324 Enzo Biochem, Inc. shares in Q4 2016, an estimated $322K.
Breithorn Capital Management first reported a position in Enzo Biochem, Inc. in Q2 2015 and held it in 6 quarters.
Breithorn Capital Management's Enzo Biochem, Inc. position peaked at $925K in Q4 2015.
109 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2016.

Based on Breithorn Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.